跳至主要内容
临床试验/CTRI/2024/01/061976
CTRI/2024/01/061976尚未招募Unknown

A cross sectional observational study on skin tissue expression of Interleukin 17 in patients of dermatophytosis

GCSMCH&RC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • all patients with clinically diagnosed and confirmed with KOH smear examination for tinea/ dermatophytic infection with age 18-60 years who are willing to sign informed consent form.

排除标准

  • A.Patients who are not willing to sign informed consent form.
  • B.Patients with age less than 18 years and more than 60 years.
  • C.Pregnant and lactating mothers.
  • D.Patients with diseases enlisted in point E&F which may interfere with expression of IL-17 in tissue.
  • E.Cutaneous disorders like- acne, hidradenitis suppurativa, psoriasis, alopecia areata, vitiligo, autoimmune bullous diseases
  • F.Systemic diseases like- multiple sclerosis, inflammatory bowel disease, systemic lupus erythematosus, asthma, Behcet’s disease, hyper IgE syndrome, systemic sclerosis
  • G.Preexisting Cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal,endocrine, immunologic, musculoskeletal, neurological, or psychiatric disease.
  • H.Major surgical or medical illness in last 4 weeks before screening, Any concomitant medication for purpose other than dermatophytosis management at presentation or within last 4 weeks before screening.
  • I.Any concomitant intake of herbal, homeopathic or other alternative therapy at presentation or within last 4 weeks before screening.
  • J.Alcohol dependence, alcohol abuse or drug abuse within the past year.
  • K.Moderate to heavy smoking ( >10 cigarettes/day) or consumption of tobacco products
  • L.Clinically significant illness within 4 weeks before the start of the study
  • M.Asthma, urticaria or other allergic type reactions after taking any medication.
  • N.Patient having pre-existing medical condition (DM HT or any other medical condition requiring concomitant medicine.) or diagnosed during screening.
  • O.Dermatophytosis independently involving scalp (T. Capitis), nail, palm (T. pedis) and sole (T. mannum).
  • P.Patients having skin lesions with secondary bacterial infections.

研究者

发起方
GCSMCH&RC

相似试验